Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 600 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,53565.8%1,62667% +5.9%
PAREXEL Informatics264.6711.3%277.9011.4% +5%
PAREXEL Consulting Services215.959.3%190.407.8% -11.83%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States984.6842.2%908.9037.4% -7.7%
Europe, Middle East & Africa451.4619.4%568.1023.4% +25.84%
Asia/Pacific269.3011.5%296.7012.2% +10.18%
United Kingdom239.6510.3%251.0010.3% +4.74%
Americas70.903%69.602.9% -1.83%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA621983Chairman & Chief Executive Officer
Mark A. Goldberg, MD561997President & Chief Operating Officer
Emma Reeve562014CFO, Principal Accounting Officer, VP & Controller
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA651986Independent Director
Patrick J. Fortune PhD, MBA701996Independent Director
Richard L. Love732002Independent Director
Ellen M. Zane652006Independent Director
Christopher J. Lindop, CPA582006Independent Director
Eduard Enrico Holdener, MD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 50,954,585 49,948,326 98.0% 0 0.0% 98.0%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,918,045 9.23%
The Vanguard Group, Inc. 4,310,745 8.09%
UBS Financial Services, Inc. 3,132,653 5.88%
Morgan Stanley & Co. LLC 2,584,111 4.85%
Fisher Asset Management LLC 2,244,444 4.21%
Hound Partners LLC 2,116,004 3.97%
SSgA Funds Management, Inc. 1,638,790 3.08%
Wellington Management Co. LLP 1,136,930 2.13%
Aberdeen Asset Managers Ltd. 1,075,841 2.02%
ClearBridge Investments LLC 1,018,554 1.91%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..0.72%3 373
INCYTE CORPORATION20.17%22 822
QUINTILES IMS HOLDINGS..0.92%18 894
CELLTRION, INC.--.--%10 747
LONZA GROUP AG1.87%10 368
SEATTLE GENETICS, INC.24.12%9 272
ALKERMES PLC-1.82%8 293
UNITED THERAPEUTICS CO..17.24%7 133
QIAGEN NV-0.71%6 669
IONIS PHARMACEUTICALS ..-1.86%5 689
ICON PLC13.94%4 803
ACADIA PHARMACEUTICALS..36.20%4 757
CHARLES RIVER LABORATO..16.16%4 193
ALNYLAM PHARMACEUTICAL..28.95%4 143
BIO-TECHNE CORP2.34%3 927
PRA HEALTH SCIENCES IN..11.25%3 766
GALAPAGOS6.94%3 199
INC RESEARCH HOLDINGS ..3.61%2 922
INTREXON CORP-3.58%2 778
IRONWOOD PHARMACEUTICA..12.10%2 506
SAGE THERAPEUTICS INC27.26%2 415
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
Applied Microarrays, Inc.
MedAptus, Inc.
Tufts University
Molecular Profiling Institute, Inc.
Agnovos Healthcare LLC
Jobs for Massachusetts, Inc.
PHT Technologies, Inc.
New England Healthcare Institute
The Leukemia & Lymphoma Society, Inc.
Caris Molecular Profiling Institute, Inc.
Center For Private Equity & Entrepreneurship
TVP Management Co. LLC
Boston Millennia Partners III LP
Tufts University School of Medicine
Press Ganey Associates, Inc.
CardioMEMS, Inc.
Harvard T.H. Chan School of Public Health
Epigenesis Pharmaceuticals LLC
MedTrust Online LLC
Sapphire Therapeutics, Inc.
Ascalon International, Inc.
University of Wisconsin Foundation
Syndevrx, Inc.
University of Illinois
PMed Management LLC
Sun Mountain Capital LLC
Translational Accelerator LLC
Cleveland Clinic Innovations
Minuteman Health, Inc.
Global Med Technologies, Inc.
The Floating Hospital, Inc.
George Washington University
PAREXEL International Ltd.
Ascalon Pharmaceuticals
CerRx, Inc.
Cancer Prevention Pharmaceuticals Inc
Swiss Cancer Foundation
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2017 People , Fundamentals and Ownership